Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood
- PMID: 1967549
Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood
Abstract
The loss of genetic material from specific chromosomal locations has been identified for a number of pediatric tumors. This loss has been taken as evidence for the importance of tumor suppressor genes at these loci in the genesis of these tumors. One of these pediatric tumors, the primitive neuroectodermal tumor of the central nervous system, has not been well studied. In this report, an analysis of primitive neuroectodermal tumors for allelic deletions on chromosomes 1p, 7q, 10, 11p, 13q, and 17p has been performed. One of ten tumors was found to have increased copies of c-myc. Three different patients were found to reduce to homozygosity at one of three different locations. Significantly, however, three of nine informative patients showed a reduction to homozygosity on chromosome 17p. Thus, primitive neuroectodermal tumor is one of a growing number of tumor types in which deletions in the short arm of chromosome 17 might be important in oncogenesis.
Similar articles
-
Genetic alterations in glioma and medulloblastoma.Cancer Metastasis Rev. 1991 Dec;10(4):289-99. doi: 10.1007/BF00554791. Cancer Metastasis Rev. 1991. PMID: 1786630 Review.
-
Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors.Cancer Res. 1991 Jan 15;51(2):639-43. Cancer Res. 1991. PMID: 1670763
-
Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.Clin Cancer Res. 1997 Mar;3(3):473-8. Clin Cancer Res. 1997. PMID: 9815707
-
Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors.Cancer Res. 1992 Jun 15;52(12):3391-5. Cancer Res. 1992. PMID: 1596898
-
Cytogenetic and molecular genetic abnormalities in primitive neuroectodermal tumors of the central nervous system.Anticancer Res. 2000 Jan-Feb;20(1A):65-73. Anticancer Res. 2000. PMID: 10769636 Review.
Cited by
-
Cellular and molecular pathology of medulloblastoma.J Neurooncol. 1996 Jul;29(1):35-43. doi: 10.1007/BF00165516. J Neurooncol. 1996. PMID: 8817414 Review.
-
p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis.Br J Cancer. 1993 Oct;68(4):801-7. doi: 10.1038/bjc.1993.431. Br J Cancer. 1993. PMID: 8398711 Free PMC article.
-
Genetic alterations in glioma and medulloblastoma.Cancer Metastasis Rev. 1991 Dec;10(4):289-99. doi: 10.1007/BF00554791. Cancer Metastasis Rev. 1991. PMID: 1786630 Review.
-
Recent advances in embryonal tumours of the central nervous system.Childs Nerv Syst. 2005 Apr;21(4):272-93. doi: 10.1007/s00381-004-1066-4. Epub 2005 Jan 29. Childs Nerv Syst. 2005. PMID: 15682321 Review.
-
Molecular genetic studies of chromosome 11 and chromosome 22q DNA sequences in pediatric medulloblastomas.J Neurooncol. 1999 Sep;44(2):119-27. doi: 10.1023/a:1006387518100. J Neurooncol. 1999. PMID: 10619495
MeSH terms
Substances
LinkOut - more resources
Medical